辅助条件塑造了适应性免疫反应,通过NLRP3 / 介质素-1促进免疫耐受性
Thais Boccia1, Weikang Pan1, Victor Fattori2
1Department of Surgery, Boston Children's Hospital - Harvard Medical School, Boston, MA, USA.
重复施用,称为辅助条件 (AC),通过扩大髓质衍生抑制细胞 (MDSCs) 产生免疫抑制状态. 这一过程依赖于NLRP3和IL-1信号传递,延迟了全源移植的移植排斥,并为移植耐受性提供了潜在的标.
科学领域:
- 免疫学 免疫学 免疫学
- 移植免疫学 移植免疫学
- 炎症研究 炎症研究
背景情况:
- 辅助剂通常会增强免疫反应.
- 反复给药 (辅助条件,AC) 可以矛盾地诱导免疫抑制.
- 骨髓原抑制细胞 (MDSCs) 在免疫调节中起着至关重要的作用.
研究的目的:
- 研究辅助条件 (AC) 诱导免疫抑制的机制.
- 为了确定骨髓衍生抑制细胞 (MDSCs) 在AC诱导的免疫耐受性中的作用.
- 阐明参与AC介导免疫抑制和移植保护的信号通路.
主要方法:
- 小鼠接受了重复的管理 (辅助调节,AC).
- 评估全源移植排斥和存活率.
- 流细胞计和细胞检测用于识别和表征MDSCs.
- 在体外和体外功能测定以评估MDSC介导的抑制.
- 基因淘汰模型 (NLRP3-/-) 和细胞因子分析 (IL-1).
主要成果:
- 通过扩大MDSCs,AC显著延迟了全源移植的拒绝.
- 由AC诱导的MDSC抑制了抗原特异性适应性免疫反应.
- AC的免疫抑制作用取决于NLRP3和IL-1信号传递.
- 在NLRP3缺陷中,取消了AC的移植保护作用.
- 由AC诱导的MDSCs表现出改变的细胞因子概况,具有减少的促炎和增加的免疫抑制因素.
结论:
- 辅助条件 (AC) 通过NLRP3/IL-1信号轴建立一个免疫抑制环境.
- MDSCs是AC诱导免疫抑制和延迟移植排斥的关键调解者.
- 准NLRP3/IL-1通路可能是促进移植中全移植耐受性的新策略.
更多相关视频
09:03Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
Published on: June 19, 2018
08:37Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
Published on: April 21, 2015
相关概念视频
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Cell-mediated Immune Responses
Special Features of Adaptive Immunity
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Cells of the Adaptive Immune Response
